Through the C‐type lectin receptor‐2, malignant endothelial cells express a protein, known as Podoplanin, that activates platelets and accelerate thrombosis although the role of Podoplanin in cancer‐associated thrombosis was only described in intracranial malignancies.33, 35. This evidence concerns the gene PDPN and cancer.